*Finology 30: New Stock Is Live* A Bet on the Future of Pharma industry📊 From painkillers to precision therapies, medicines have become an inseparable part of human life. Thanks to medical progress, global life expectancy has soared. Global life expectancy has risen from approximately 45 years in 1950 to nearly 73 years today. In fact, for almost two centuries, record life expectancy has been increasing by around 3 years per decade, mainly driven by advances in medicine. *As per the IQVIA report:* - Global medicine market is expected to be approximately $2.3 trillion by 2028 - Projected CAGR: 5%–8% over 2024–2028 With ageing populations, rising chronic diseases, and greater access to healthcare, pharma is set to remain a secular growth story. Our latest pick? A resilient pharma player with a proven product portfolio and global reach. *Why we like it:* - Deep expertise in essential generics and branded formulations. - Strong balance sheet with zero debt-equity ratio. - Exposure to both regulated and emerging markets. This company is quietly compounding in one of the most essential industries of our time. And here's the kicker — *it's still undervalued by around 18% from our "Buy It Below price".* Think you know the stock? Read our detailed report to confirm. Reveal Stock → https://tinyurl.com/newstockupdate